摘要
新型高选择性药品的出现推动更大更复杂试验的趋势。日益增长的治疗复杂性激发西欧和北美的研究者寻找方法来实现临床增长的要求。
The emergence of a new class of highly selective drugs is driving a trend towards larger and more intricate trials. This growing therapeutic complexity is motivating investigators in Western Europe and North America to look further to fulfil the increasing demands of clinical research.
